Laza Medical

About Laza Medical

Laza Medical, Inc. is a medical technology firm developing an imaging solution for cardiovascular interventions that integrates artificial intelligence (AI) software with advanced robotics. The company operates within the interventional cardiology market, specifically targeting the structural heart and electrophysiology segments. Its business model centers on creating and commercializing this high-tech imaging system for clinicians. Laza Medical emerged in 2022 from Shifamed, a specialized medical innovation hub founded by serial entrepreneur Amr Salahieh, who also serves as Laza's chairman.

The company's primary offering is an AI-powered, robotically-assisted imaging system designed to optimize procedural workflows in the catheterization lab. This system aims to provide high-quality imaging and sophisticated procedure navigation through a simplified user interface, making it accessible to a broader range of clinicians. A key benefit is its potential to replace or reduce reliance on X-ray fluoroscopy, thereby minimizing radiation exposure for both patients and medical staff. By enhancing diagnostic confidence and the guidance of cardiac interventions, the technology addresses a critical need for improved imaging in complex cases.

In December 2023, Laza Medical secured $36 million in a Series A financing round. The round was led by The Capital Partnership (TCP), with notable participation from GE HealthCare, PA MedTech VC fund, Unorthodox Ventures, and Dara Holdings. These funds are allocated to accelerate product development and team expansion. Concurrently with the financing, the company appointed Pablo Garcia as General Manager. Garcia brings extensive experience from the medical device industry, having previously served as Vice President of Digital Solutions for Johnson & Johnson and as the technical co-founder of Verb Surgical, a robotics venture between Google and Johnson & Johnson.